Ameriprise
PRPH

Ameriprise’s ProPhase Labs PRPH Stock Holding History

Ameriprise’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,273
Closed -$673K – 3947
2023
Q2 		$673K Buy
9,273
+428
+5% +$34.8K ﹤0.01% 3328
2023
Q1 		$674K Hold
8,845
– – ﹤0.01% 3313
2022
Q4 		$852K Sell
8,845
-104
-1% -$11.2K ﹤0.01% 3208
2022
Q3 		$1.01M Sell
8,949
-4,704
-34% -$547K ﹤0.01% 3108
2022
Q2 		$1.73M Sell
13,653
-141
-1% -$12.4K ﹤0.01% 2864
2022
Q1 		$965K Buy
13,794
+329
+2% +$22.9K ﹤0.01% 3232
2021
Q4 		$964K Buy
+13,465
New +$838K ﹤0.01% 3278

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Ameriprise's PRPH Position: Q3 2023 in Review

Ameriprise sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 9,273 shares — an estimated $673K sold.

Ameriprise first reported a position in PRPH in Q4 2021 and held it in 7 quarters. The position peaked at $1.73M in Q2 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • Ameriprise reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • Ameriprise sold 9,273 ProPhase Labs shares in Q3 2023, an estimated $673K.
  • Ameriprise first reported a position in ProPhase Labs in Q4 2021 and held it in 7 quarters.
  • Ameriprise's ProPhase Labs position peaked at $1.73M in Q2 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.